Form 8-K - Current report:
SEC Accession No. 0000950170-25-057685
Filing Date
2025-04-24
Accepted
2025-04-24 08:30:13
Documents
14
Period of Report
2025-04-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vivs-20250423.htm   iXBRL 8-K 56309
2 EX-3.1 vivs-ex3_1.htm EX-3.1 10362
3 EX-3.2 vivs-ex3_2.htm EX-3.2 276687
4 EX-99.1 vivs-ex99_1.htm EX-99.1 16703
  Complete submission text file 0000950170-25-057685.txt   529632

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vivs-20250423.xsd EX-101.SCH 26969
16 EXTRACTED XBRL INSTANCE DOCUMENT vivs-20250423_htm.xml XML 5119
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
VivoSim Labs, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35996 | Film No.: 25863711
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)